Analysis of cancer incidence and mortality data in Heilongjiang province cancer registries, China, 2015

被引:5
作者
Huixin Sun [1 ]
Bingbing Song [1 ]
Maoxiang Zhang [1 ]
机构
[1] Institute of Cancer Prevention and Treatment, Harbin Medical University,Heilongjiang Academy of Medical Science,Heilongjiang Cancer Center
关键词
tumor registration; incidence; mortality; Heilongjiang province; China;
D O I
暂无
中图分类号
R73-31 [肿瘤学调查与统计];
学科分类号
100214 ;
摘要
Objective In recent years, the rising incidence of cancer has increased patients’ living and economic burdens. This study analyzed the incidence and death due to malignant tumors in tumor registries in Heilongjiang province(China) in 2015 to provide a scientific basis for the prevention and treatment of malignant tumors in this province. Methods Data on tumor incidence and patient deaths were collected from seven tumor registries in Heilongjiang province(China) in 2015. According to the stratification of urban and rural areas and patient sex, the crude, standard, and accumulative rates(0–74 years of age) were calculated. The 2000 China Population Census data and Segi’s standard population were used to calculate the age-standardized rates. Results In 2015, the incidence rate of malignant tumors in Heilongjiang cancer registries was 259.90/100 000. The age-standardized incidence rates in the Chinese and world standard populations were 158.89/100 000 and 155.06/100 000, respectively, with a cumulative incidence rate(0–74 years) of 17.68%. The incidence of malignant tumors in urban areas was 273.55/100 000, while that in rural areas was 220.32/100 000. The incidence of malignant tumors in men was 270.89/100 000, higher than that in women(249.04/100 000). Lung cancer had the highest incidence, followed by breast cancer, liver cancer, colorectal cancer, and thyroid cancer. The mortality rate of malignant tumors in Heilongjiang cancer registries was 164.69/100 000. The age-standardized mortality rates in Chinese and in world standard populations were 95.29/100 000 and 94.35/100 000, respectively, with a cumulative mortality rate(0–74 years) of 10.44%. The mortality rate of malignant tumors in urban areas was 169.51/100 000, while that in rural areas was 150.72/100 000. The mortality rate of malignant tumors in men was 201.64/100 000, higher than that in women(128.21/100 000). Lung cancer had the highest mortality, followed by liver cancer, stomach cancer, colorectal cancer, and breast cancer.Conclusion Lung, liver, breast, and colorectal cancers were the most common cancers in Heilongjiang province, China, and should be considered the key cancer types for prevention and treatment. Moreover, the incidence of thyroid cancer is increasing, and thus early preventative measures should be implemented.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 9 条
  • [1] 2015年中国分地区恶性肿瘤发病和死亡分析
    孙可欣
    郑荣寿
    张思维
    曾红梅
    邹小农
    陈茹
    顾秀瑛
    魏文强
    赫捷
    [J]. 中国肿瘤, 2019, 28 (01) : 1 - 11
  • [2] 2014年黑龙江省肿瘤登记地区恶性肿瘤发病死亡分析
    孙惠昕
    陈王洋
    张茂祥
    宋冰冰
    [J]. 中华肿瘤防治杂志, 2018, 25 (20) : 1407 - 1412
  • [3] Expenditure of hospital care on cancer in China; from 2011 to 2015.[J].Yue Cai;Ming Xue;Wanqing Chen;Maogui Hu;Zhiwen Miao;Lan Lan;Rongshou Zheng;Qun Meng;.Chinese Journal of Cancer Research.2017, 03
  • [4] 2009-2012年哈尔滨市上消化道癌早诊早治效果评价
    孙惠昕
    宋冰冰
    陈王洋
    杨凤娟
    [J]. 现代肿瘤医学, 2015, 23 (17) : 2518 - 2521
  • [5] Clinical observation of capecitabine monotherapy in elderly patients with advanced breast cancer
    Miao Zhang
    Zhaozhe Liu
    Zhendong Zheng
    Tao Han
    Yaling Han
    Min Song
    Xiaodong Xie
    [J]. Oncology and Translational Medicine, 2015, 1 (02) : 78 - 81
  • [6] Securing global access to innovations in women's cancer care and control
    Konecny, Gottfried E.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (01) : 1 - 3
  • [7] Cancer survival in C hina; 2003–2005: A population‐based study.[J].Hongmei Zeng;Rongshou Zheng;Yuming Guo;Siwei Zhang;Xiaonong Zou;Ning Wang;Limei Zhang;Jingao Tang;Jianguo Chen;Kuangrong Wei;Suqin Huang;Jian Wang;Liang Yu;Deli Zhao;Guohui Song;Jianshun Chen;Yongzhou Shen;Xiaoping Yang;Xiaoping Gu;Feng Jin;Qilong Li;Yanhua Li;Hengming Ge;Fengdong Zhu;Jianmei Dong;Guoping Guo;Ming Wu;Lingbin Du;Xibin Sun;Yutong He;Michel P Coleman;Peter Baade;Wanqing Chen;Xue Qin Yu.Int. J. Cancer.2015, 8
  • [8] Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness.[J].D. Max Parkin;Freddie Bray.European Journal of Cancer.2008, 5
  • [9] Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability; validity and timeliness.[J].Freddie Bray;D. Max Parkin.European Journal of Cancer.2008, 5